Danaher Corporation (DHR)
Stock Health Score
Potential Growth Score
Dividend Score
Company Profile
Danaher Corporation designs manufactures and markets professional medical industrial and commercial products and services worldwide The company operates through three segments Life Sciences Diagnostics and Environmental Applied Solutions The Life Sciences segment provides mass spectrometers flow cytometry genomics lab automation centrifugation particle counting and characterization microscopes genomics consumables and Gene and Cell Therapy This segment also offers bioprocess technologies consumables and services and filtration separation and purification technologies to the pharmaceutical and biopharmaceutical food and beverage medical and life sciences companies as well as universities medical schools and research institutions and various industrial manufacturers The Diagnostics segment provides chemistry immunoassay microbiology and automation systems as well as hematology molecular acute care and pathology diagnostics products This segment offers clinical instruments reagents consumables software and services for hospitals physicians offices reference laboratories and other critical care settings The Environmental Applied Solutions segment offers instrumentation consumables software services and disinfection systems to analyze treat and manage ultrapure potable industrial waste ground source and ocean water in residential commercial industrial and natural resource applications This segment also provides instruments software services and consumables for various color and appearance management packaging design and quality management packaging converting printing marking coding and traceability applications for consumer pharmaceutical and industrial products The company was formerly known as Diversified Mortgage Investors Inc and changed its name to Danaher Corporation in 1984 Danaher Corporation was founded in 1969 and is headquartered in Washington the District of Columbia
Dividend Summary
Last Payment | Mar 22, 1993 | Next Expected | Nov 30, 2024 |
Amount | $0.0300 | Probability | 25.0% |
Current Yield | 0.11% | Previous Yield | 0.00% |
Key Metrics
Beta | 0.88 | P/E Ratio | 29.85 |
Market Cap | $165.08B |
AI Analysis